PMID- 35242275 OWN - NLM STAT- MEDLINE DCOM- 20220324 LR - 20220324 IS - 1942-0994 (Electronic) IS - 1942-0900 (Print) IS - 1942-0994 (Linking) VI - 2022 DP - 2022 TI - Diet-Induced High Serum Levels of Trimethylamine-N-oxide Enhance the Cellular Inflammatory Response without Exacerbating Acute Intracerebral Hemorrhage Injury in Mice. PG - 1599747 LID - 10.1155/2022/1599747 [doi] LID - 1599747 AB - Trimethylamine-N-oxide (TMAO), an intestinal flora metabolite of choline, may aggravate atherosclerosis by inducing a chronic inflammatory response and thereby promoting the occurrence of cerebrovascular diseases. Knowledge about the influence of TMAO-related inflammatory response on the pathological process of acute stroke is limited. This study was designed to explore the effects of TMAO on neuroinflammation, brain injury severity, and long-term neurologic function in mice with acute intracerebral hemorrhage (ICH). We fed mice with either a regular chow diet or a chow diet supplemented with 1.2% choline pre- and post-ICH. In this study, we measured serum levels of TMAO with ultrahigh-performance liquid chromatography-tandem mass spectrometry at 24 h and 72 h post-ICH. The expression level of P38-mitogen-protein kinase (P38-MAPK), myeloid differentiation factor 88 (MyD88), high-mobility group box1 protein (HMGB1), and interleukin-1beta (IL-1beta) around hematoma was examined by western blotting at 24 h. Microglial and astrocyte activation and neutrophil infiltration were examined at 72 h. The lesion was examined on days 3 and 28. Neurologic deficits were examined for 28 days. A long-term choline diet significantly increased serum levels of TMAO compared with a regular diet at 24 h and 72 h after sham operation or ICH. Choline diet-induced high serum levels of TMAO did not enhance the expression of P38-MAPK, MyD88, HMGB1, or IL-1beta at 24 h. However, it did increase the number of activated microglia and astrocytes around the hematoma at 72 h. Contrary to our expectations, it did not aggravate acute or long-term histologic damage or neurologic deficits after ICH. In summary, choline diet-induced high serum levels of TMAO increased the cellular inflammatory response probably by activating microglia and astrocytes. However, it did not aggravate brain injury or worsen long-term neurologic deficits. Although TMAO might be a potential risk factor for cerebrovascular diseases, this exploratory study did not support that TMAO is a promising target for ICH therapy. CI - Copyright (c) 2022 Caizhen Li et al. FAU - Li, Caizhen AU - Li C AUID- ORCID: 0000-0001-6854-116X AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Zhu, Li AU - Zhu L AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Dai, Yinming AU - Dai Y AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Zhang, Zhiying AU - Zhang Z AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Huang, Leo AU - Huang L AD - Department of Psychology, University of Toronto, Toronto, Ontario, Canada. FAU - Wang, Tom J AU - Wang TJ AD - Winston Churchill High School, Potomac, Maryland, USA. FAU - Fu, Peiji AU - Fu P AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Li, Yinuo AU - Li Y AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. FAU - Wang, Jian AU - Wang J AUID- ORCID: 0000-0003-2291-640X AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. AD - Department of Anatomy, College of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China. FAU - Jiang, Chao AU - Jiang C AUID- ORCID: 0000-0001-5588-4294 AD - Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. LA - eng PT - Journal Article DEP - 20220216 PL - United States TA - Oxid Med Cell Longev JT - Oxidative medicine and cellular longevity JID - 101479826 RN - 0 (IL1B protein, mouse) RN - 0 (Interleukin-1beta) RN - 0 (Methylamines) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - FLD0K1SJ1A (trimethyloxamine) RN - N91BDP6H0X (Choline) SB - IM MH - Acute Disease MH - Animals MH - Astrocytes/*metabolism MH - Brain Injuries/*blood/*complications/microbiology MH - Cerebral Hemorrhage/*blood/*complications/microbiology MH - Choline/*adverse effects MH - Diet/*adverse effects MH - Disease Models, Animal MH - Gastrointestinal Microbiome MH - Inflammation/blood/chemically induced MH - Interleukin-1beta/metabolism MH - Male MH - Methylamines/*blood MH - Mice MH - Mice, Inbred C57BL MH - Microglia/*metabolism MH - Neutrophil Infiltration/drug effects MH - Neutrophils/immunology MH - Signal Transduction/*drug effects MH - p38 Mitogen-Activated Protein Kinases/metabolism PMC - PMC8886754 COIS- The authors declare that they have no competing interests. EDAT- 2022/03/05 06:00 MHDA- 2022/03/25 06:00 PMCR- 2022/02/16 CRDT- 2022/03/04 05:40 PHST- 2021/09/28 00:00 [received] PHST- 2022/01/27 00:00 [accepted] PHST- 2022/03/04 05:40 [entrez] PHST- 2022/03/05 06:00 [pubmed] PHST- 2022/03/25 06:00 [medline] PHST- 2022/02/16 00:00 [pmc-release] AID - 10.1155/2022/1599747 [doi] PST - epublish SO - Oxid Med Cell Longev. 2022 Feb 16;2022:1599747. doi: 10.1155/2022/1599747. eCollection 2022.